Tesis Biosciences announces project to study veterans and civilians with mild traumatic brain injury
Company in preparation for applying for formal FDA approval PHOENIX, December 9, 2022 /PRNewswire/ — Tesis Biosciences, the leader in targeted genetic sequencing, has announced a study project designed to develop molecular biomarkers to accurately differentiate mild traumatic brain injury (mTBI) from post-traumatic stress disorder (PTSD). ). Enabling accurate diagnosis can improve treatments for people …